https://www.marketscreener.com/quote/stock/CLARITY-PHARMACEUTICALS-L-125137802/news/Clarity-Pharmaceuticals-First-participant-treated-in-the-highest-dose-cohort-of-neuroblastoma-tria-44712973/?utm_source=telegram&utm_medium=social&utm_campaign=share